Kamilaris Crystal D C, Faucz Fabio R, Andriessen Victoria C, Nilubol Naris, Lee Chyi-Chia Richard, Ahlman Mark A, Hannah-Shmouni Fady, Stratakis Constantine A
Section on Endocrinology and Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD, USA.
Endocrine Surgery Section, Surgical Oncology Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
J Endocr Soc. 2021 Jan 25;5(4):bvab007. doi: 10.1210/jendso/bvab007. eCollection 2021 Apr 1.
Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of ACTH-independent Cushing syndrome (CS) associated mostly with Carney complex (CNC), a rare autosomal dominant multiple neoplasia syndrome. More than two-thirds of familial cases and approximately one-third of sporadic cases of CNC harbor germline inactivating defects. Increasingly sensitive technologies for the detection of genetic defects such as next-generation sequencing (NGS) have further highlighted the importance of mosaicism in human disease.
A 33-year-old woman was diagnosed with ACTH-independent CS with abdominal computed tomography showing bilateral micronodular adrenal hyperplasia with a left adrenal adenoma. She underwent left adrenalectomy with pathology demonstrating PPNAD with a 1.5-cm pigmented adenoma. DNA analysis by Sanger sequencing revealed 2 different variants in the adenoma that were absent from DNA extracted from blood and saliva: c.682C > T and c.974-2A > G. "Deep" NGS revealed that 0.31% of DNA copies extracted from blood and saliva did in fact carry the c.682C > T variant, suggesting low-level mosaicism for this defect.
We present a case of PPNAD due to low-level mosaicism for a defect which led to the formation of an adenoma due to a second, adrenal-specific, somatic mutation. The identification of mosaicism for , depending on the number and distribution of cells affected has implications for genetic counseling and tumor surveillance. This is the first recorded case of a patient with mosaicism, PPNAD, and an adenoma forming due to complete inactivation of in adrenal tissue from a second, somatic-only, coding sequence mutation.
原发性色素沉着性结节性肾上腺皮质疾病(PPNAD)是促肾上腺皮质激素(ACTH)非依赖性库欣综合征(CS)的罕见病因,主要与卡尼综合征(CNC)相关,后者是一种罕见的常染色体显性多发性肿瘤综合征。超过三分之二的CNC家族性病例和约三分之一的散发性病例存在种系失活缺陷。诸如下一代测序(NGS)等用于检测基因缺陷的日益灵敏的技术进一步凸显了嵌合体在人类疾病中的重要性。
一名33岁女性被诊断为ACTH非依赖性CS,腹部计算机断层扫描显示双侧微结节性肾上腺增生伴左肾上腺腺瘤。她接受了左肾上腺切除术,病理显示为PPNAD伴一个1.5厘米的色素沉着腺瘤。通过桑格测序进行的DNA分析显示,腺瘤中有2种不同的变异,而从血液和唾液中提取的DNA中不存在这些变异:c.682C>T和c.974-2A>G。“深度”NGS显示,从血液和唾液中提取的DNA拷贝实际上有0.31%携带c.682C>T变异,表明该缺陷存在低水平嵌合体。
我们报告了一例因低水平嵌合体导致的PPNAD病例,该缺陷因另一种肾上腺特异性体细胞突变导致腺瘤形成。根据受影响细胞的数量和分布来识别嵌合体,对遗传咨询和肿瘤监测具有重要意义。这是首例记录在案的患者,其存在嵌合体、PPNAD,且由于来自另一个仅体细胞的编码序列突变导致肾上腺组织中的[具体基因]完全失活而形成腺瘤。